vs
CATALYST PHARMACEUTICALS, INC.（CPRX）与PLUG POWER INC（PLUG）财务数据对比。点击上方公司名可切换其他公司
PLUG POWER INC的季度营收约是CATALYST PHARMACEUTICALS, INC.的1.5倍（$225.2M vs $152.6M），CATALYST PHARMACEUTICALS, INC.净利率更高（34.5% vs -375.6%，领先410.1%），PLUG POWER INC同比增速更快（17.6% vs 7.6%），CATALYST PHARMACEUTICALS, INC.自由现金流更多（$44.9M vs $-153.0M），过去两年PLUG POWER INC的营收复合增速更高（36.8% vs 24.5%）
Catalyst Pharmaceuticals是一家总部位于美国佛罗里达州科勒尔盖布尔斯的生物制药企业，专注于罕见病药物研发。核心产品包括用于治疗兰伯特-伊顿肌无力综合征（LEMS）的氨吡啶磷酸盐，商品名为Firdapse。该药物2018年11月获FDA批准，除原有成人适应症外，还可用于6岁及以上的LEMS儿童患者。
普拉格能源是一家美国企业，专注于氢燃料电池和电解槽系统的研发，其产品可替代电动设备及车辆所使用的传统电池。公司总部位于纽约州斯林格兰兹，在华盛顿州斯波坎、纽约州罗切斯特均设有生产运营基地。
CPRX vs PLUG — 直观对比
营收规模更大
PLUG
是对方的1.5倍
$152.6M
营收增速更快
PLUG
高出10.0%
7.6%
净利率更高
CPRX
高出410.1%
-375.6%
自由现金流更多
CPRX
多$197.9M
$-153.0M
两年增速更快
PLUG
近两年复合增速
24.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $152.6M | $225.2M |
| 净利润 | $52.7M | $-846.0M |
| 毛利率 | 82.9% | 2.4% |
| 营业利润率 | 40.5% | -338.9% |
| 净利率 | 34.5% | -375.6% |
| 营收同比 | 7.6% | 17.6% |
| 净利润同比 | -5.8% | 36.7% |
| 每股收益（稀释后） | $0.40 | $-0.70 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPRXPLUG
| Q4 25 | $152.6M | $225.2M | ||
| Q3 25 | $148.4M | $177.1M | ||
| Q2 25 | $146.6M | $174.0M | ||
| Q1 25 | $141.4M | $133.7M | ||
| Q4 24 | $141.8M | $191.5M | ||
| Q3 24 | $128.7M | $173.7M | ||
| Q2 24 | $122.7M | $143.3M | ||
| Q1 24 | $98.5M | $120.3M |
净利润CPRXPLUG
| Q4 25 | $52.7M | $-846.0M | ||
| Q3 25 | $52.8M | $-361.9M | ||
| Q2 25 | $52.1M | $-227.1M | ||
| Q1 25 | $56.7M | $-196.7M | ||
| Q4 24 | $55.9M | $-1.3B | ||
| Q3 24 | $43.9M | $-211.2M | ||
| Q2 24 | $40.8M | $-262.3M | ||
| Q1 24 | $23.3M | $-295.8M |
毛利率CPRXPLUG
| Q4 25 | 82.9% | 2.4% | ||
| Q3 25 | 84.7% | -67.9% | ||
| Q2 25 | 85.9% | -30.7% | ||
| Q1 25 | 87.3% | -55.3% | ||
| Q4 24 | 84.7% | -122.5% | ||
| Q3 24 | 85.0% | -57.6% | ||
| Q2 24 | 87.4% | -91.6% | ||
| Q1 24 | 87.3% | -132.3% |
营业利润率CPRXPLUG
| Q4 25 | 40.5% | -338.9% | ||
| Q3 25 | 44.7% | -197.0% | ||
| Q2 25 | 45.2% | -101.7% | ||
| Q1 25 | 44.8% | -133.5% | ||
| Q4 24 | 44.3% | -678.7% | ||
| Q3 24 | 39.6% | -124.4% | ||
| Q2 24 | 44.2% | -170.7% | ||
| Q1 24 | 27.5% | -215.7% |
净利率CPRXPLUG
| Q4 25 | 34.5% | -375.6% | ||
| Q3 25 | 35.6% | -204.4% | ||
| Q2 25 | 35.6% | -130.5% | ||
| Q1 25 | 40.1% | -147.1% | ||
| Q4 24 | 39.4% | -697.5% | ||
| Q3 24 | 34.1% | -121.5% | ||
| Q2 24 | 33.2% | -183.0% | ||
| Q1 24 | 23.6% | -245.9% |
每股收益（稀释后）CPRXPLUG
| Q4 25 | $0.40 | $-0.70 | ||
| Q3 25 | $0.42 | $-0.31 | ||
| Q2 25 | $0.41 | $-0.20 | ||
| Q1 25 | $0.45 | $-0.21 | ||
| Q4 24 | $0.44 | $-1.61 | ||
| Q3 24 | $0.35 | $-0.25 | ||
| Q2 24 | $0.33 | $-0.36 | ||
| Q1 24 | $0.19 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $709.2M | $368.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $954.3M | $978.1M |
| 总资产 | $1.1B | $2.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPRXPLUG
| Q4 25 | $709.2M | $368.5M | ||
| Q3 25 | $689.9M | $165.9M | ||
| Q2 25 | $652.8M | $140.7M | ||
| Q1 25 | $580.7M | $295.8M | ||
| Q4 24 | $517.6M | $205.7M | ||
| Q3 24 | $442.3M | $93.9M | ||
| Q2 24 | $375.7M | $62.4M | ||
| Q1 24 | $310.4M | $172.9M |
总债务CPRXPLUG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $3.7M | ||
| Q1 24 | — | $3.8M |
股东权益CPRXPLUG
| Q4 25 | $954.3M | $978.1M | ||
| Q3 25 | $920.2M | $1.4B | ||
| Q2 25 | $856.0M | $1.7B | ||
| Q1 25 | $794.3M | $1.9B | ||
| Q4 24 | $727.6M | $1.7B | ||
| Q3 24 | $660.9M | $3.0B | ||
| Q2 24 | $608.7M | $3.0B | ||
| Q1 24 | $561.4M | $2.9B |
总资产CPRXPLUG
| Q4 25 | $1.1B | $2.6B | ||
| Q3 25 | $1.1B | $3.1B | ||
| Q2 25 | $971.9M | $3.4B | ||
| Q1 25 | $908.9M | $3.6B | ||
| Q4 24 | $851.4M | $3.6B | ||
| Q3 24 | $772.0M | $4.7B | ||
| Q2 24 | $706.4M | $4.8B | ||
| Q1 24 | $646.7M | $4.8B |
负债/权益比CPRXPLUG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $44.9M | $-148.6M |
| 自由现金流经营现金流 - 资本支出 | $44.9M | $-153.0M |
| 自由现金流率自由现金流/营收 | 29.4% | -67.9% |
| 资本支出强度资本支出/营收 | 0.0% | 1.9% |
| 现金转化率经营现金流/净利润 | 0.85× | — |
| 过去12个月自由现金流最近4个季度 | — | $-647.0M |
8季度趋势，按日历期对齐
经营现金流CPRXPLUG
| Q4 25 | $44.9M | $-148.6M | ||
| Q3 25 | $32.4M | $-89.8M | ||
| Q2 25 | $71.3M | $-191.8M | ||
| Q1 25 | $60.0M | $-105.6M | ||
| Q4 24 | $70.9M | $-131.2M | ||
| Q3 24 | $72.9M | $-174.9M | ||
| Q2 24 | $64.1M | $-254.7M | ||
| Q1 24 | $31.9M | $-167.7M |
自由现金流CPRXPLUG
| Q4 25 | $44.9M | $-153.0M | ||
| Q3 25 | — | $-117.5M | ||
| Q2 25 | $71.3M | $-230.4M | ||
| Q1 25 | — | $-146.0M | ||
| Q4 24 | $70.8M | $-165.2M | ||
| Q3 24 | $72.6M | $-234.2M | ||
| Q2 24 | $64.1M | $-356.0M | ||
| Q1 24 | $31.7M | $-260.3M |
自由现金流率CPRXPLUG
| Q4 25 | 29.4% | -67.9% | ||
| Q3 25 | — | -66.4% | ||
| Q2 25 | 48.6% | -132.5% | ||
| Q1 25 | — | -109.2% | ||
| Q4 24 | 49.9% | -86.3% | ||
| Q3 24 | 56.4% | -134.8% | ||
| Q2 24 | 52.3% | -248.4% | ||
| Q1 24 | 32.2% | -216.5% |
资本支出强度CPRXPLUG
| Q4 25 | 0.0% | 1.9% | ||
| Q3 25 | 0.0% | 15.6% | ||
| Q2 25 | 0.0% | 22.2% | ||
| Q1 25 | 0.0% | 30.3% | ||
| Q4 24 | 0.1% | 17.7% | ||
| Q3 24 | 0.2% | 34.1% | ||
| Q2 24 | 0.0% | 70.7% | ||
| Q1 24 | 0.2% | 77.0% |
现金转化率CPRXPLUG
| Q4 25 | 0.85× | — | ||
| Q3 25 | 0.61× | — | ||
| Q2 25 | 1.37× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.57× | — | ||
| Q1 24 | 1.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPRX
| Firdapse | $97.6M | 64% |
| Agamree | $35.3M | 23% |
| Fycompa | $19.6M | 13% |
PLUG
| Sales Of Equipment And Related Infrastructure | $111.6M | 50% |
| Services Performed On Fuel Cell Systems And Related Infrastructure | $41.5M | 18% |
| Power Purchase Agreements | $36.1M | 16% |
| Sale Of Cryogenic Equipment | $20.0M | 9% |
| Sales Of Fuel Cell Systems | $11.2M | 5% |
| Other | $4.8M | 2% |
